Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▲ | 5y |
|---|---|---|---|---|---|---|---|
| Sintx Technologies Inc. | 6.020% | -2.118% | 81.659% | -96.896% | -88.315% | -99.964% | - |
| InVivo Therapeutics Holdings | -5.520% | -6.098% | 54.774% | -75.862% | -55.233% | -99.935% | -99.964% |
| Thermogenesis Holdings Inc. | - | -3.226% | -18.367% | -66.851% | 5.263% | -99.306% | -99.466% |
| Trevena Inc. | -0.690% | 4.221% | 0.987% | -81.937% | -41.408% | -98.924% | -98.915% |
| Accelerate Diagnostics Inc. | 1.700% | 0.000% | 13.548% | -87.862% | -75.691% | -98.545% | - |
| Salarius Pharmaceuticals Inc. | -4.230% | -0.971% | -0.971% | -77.826% | -26.486% | -98.326% | -99.993% |
| Qualigen Therapeutics Inc. | -3.570% | -5.556% | -24.444% | -72.414% | -45.709% | -98.235% | - |
| Forte Biosciences Inc. | -0.760% | -1.504% | -2.963% | -31.053% | 1.550% | -97.500% | - |
| Evoke Pharma Inc. | -2.880% | -2.885% | -21.553% | -79.175% | -57.249% | -97.315% | -94.685% |
| Kala Pharmaceuticals Inc. | 0.970% | 0.080% | -9.124% | -54.529% | -3.758% | -97.182% | - |
| Novavax Inc. | -2.300% | 2.536% | 1.958% | -38.460% | -6.719% | -97.117% | -43.564% |
| Heat Biologics Inc. | -3.850% | -15.500% | 14.189% | -72.742% | -61.937% | -96.725% | - |
| Carisma Therapeutics Inc. | 1.450% | -6.585% | -14.328% | -87.691% | -47.190% | -96.704% | -97.497% |
| Bluebird Bio Inc. | -6.530% | 7.624% | -15.845% | -77.181% | -27.525% | -96.391% | - |
| Seres Therapeutics Inc | -24.660% | -26.019% | 1.900% | -86.408% | -47.603% | -95.938% | - |
| TherapeuticsMD Inc. | 5.260% | 5.263% | -10.000% | -47.368% | -14.286% | -95.909% | -98.925% |
| Aspira Womens Health Inc. | -3.450% | -7.285% | 19.658% | -24.119% | -30.864% | -95.380% | -83.437% |
| Atara Biotherapeutics Inc. | -3.640% | -21.500% | -27.218% | -80.413% | 4.072% | -95.264% | - |
| Acelrx Pharmaceuticals Inc. | 1.190% | 0.214% | -10.496% | 47.022% | 32.486% | -94.821% | -98.488% |
| Sangamo Therapeutics Inc. | -6.110% | -3.677% | -9.758% | -59.550% | -18.466% | -94.584% | -95.337% |
| Fate Therapeutics Inc. | -6.250% | -6.708% | -44.064% | -30.055% | -3.009% | -94.524% | - |
| Aclaris Therapeutics Inc | -4.760% | 1.526% | 2.725% | -85.216% | 19.053% | -94.276% | - |
| Fibrogen Inc. | -18.050% | 11.681% | -29.567% | -93.478% | 22.849% | -93.647% | - |
| Cara Therapeutics Inc. | -3.160% | -4.143% | -16.412% | -82.482% | -1.586% | -93.393% | -95.893% |
| Pacific Biosciences of California Inc. | -9.070% | 0.542% | -51.020% | -86.020% | -83.355% | -92.381% | -75.989% |